{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:03:27Z","timestamp":1786133007652,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1681\/asn.2015101171","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T22:09:15Z","timestamp":1448921355000},"page":"1584-1586","source":"Crossref","is-referenced-by-count":2,"title":["Busy Bs"],"prefix":"10.1681","volume":"27","author":[{"given":"Howard","family":"Trachtman","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Nephrology, New York University Langone Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2015,11,30]]},"reference":[{"key":"B1-20230819","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc055495","article-title":"Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment","volume":"354","author":"Pescovitz","year":"2006","journal-title":"N Engl J Med"},{"key":"B2-20230819","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","article-title":"Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: A multicentric series of 22 cases","volume":"23","author":"Guigonis","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"B3-20230819","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","article-title":"Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: Multicentric report","volume":"5","author":"Gulati","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B4-20230819","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int"},{"key":"B5-20230819","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1681\/ASN.2013030251","article-title":"Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","volume":"25","author":"Ruggenenti","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B6-20230819","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","article-title":"Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine","volume":"25","author":"Fujinaga","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B7-20230819","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: A randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8-20230819","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: A multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"key":"B9-20230819","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1681\/ASN.2014080799","article-title":"Rituximab in children with steroid-dependent nephrotic syndrome: A multicenter, open-label, noninferiority, randomized controlled trial","volume":"26","author":"Ravani","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1681\/ASN.2015050523","article-title":"B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome","volume":"27","author":"Colucci","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1542\/peds.2015-0486","article-title":"Mycophenolate mofetil following rituximab in children with steroid-resistant nephrotic syndrome","volume":"136","author":"Basu","year":"2015","journal-title":"Pediatrics"},{"key":"B12-20230819","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00467-006-0316-y","article-title":"Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome","volume":"22","author":"Takahashi","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"B13-20230819","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/pr.2014.159","article-title":"Effects of gluten-free, dairy-free diet on childhood nephrotic syndrome and gut microbiota","volume":"77","author":"Uy","year":"2015","journal-title":"Pediatr Res"},{"key":"B14-20230819","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: A disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"B15-20230819","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","article-title":"Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis","volume":"123","author":"Sfikakis","year":"2007","journal-title":"Clin Immunol"},{"key":"B16-20230819","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","article-title":"Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome","volume":"139","author":"Liu","year":"2011","journal-title":"Clin Immunol"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1681\/ASN.2014030247","article-title":"HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome","volume":"26","author":"Gbadegesin","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.semnephrol.2011.06.003","article-title":"Focal and segmental glomerulosclerosis: Multiple pathways are involved","volume":"31","author":"Meyrier","year":"2011","journal-title":"Semin Nephrol"},{"key":"B19-20230819","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201606000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:27:20Z","timestamp":1786130840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201606000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,30]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2015101171","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,30]]}}}